Efficacy of Systemic Bevacizumab for Recurrent Respiratory Papillomatosis with Pulmonary Involvement.

MLA

So, Raymond J., et al. “Efficacy of Systemic Bevacizumab for Recurrent Respiratory Papillomatosis with Pulmonary Involvement.” Laryngoscope, vol. 134, no. 2, Feb. 2024, pp. 577–81. EBSCOhost, https://doi.org/10.1002/lary.30893.

APA

So, R. J., Hidalgo Lopez, J. C., Ballestas, S. A., Klein, A. M., Steuer, C., Shin, D. M., Abousaud, M., Teng, Y., Saba, N. F., Tkaczuk, A. T., Schaefer, E. S., Seiwert, T. Y., McClellan, K., & Best, S. R. (2024). Efficacy of Systemic Bevacizumab for Recurrent Respiratory Papillomatosis with Pulmonary Involvement. Laryngoscope, 134(2), 577–581. https://doi.org/10.1002/lary.30893

Chicago

So, Raymond J., Julio C. Hidalgo Lopez, Samir A. Ballestas, Adam M. Klein, Conor Steuer, Dong M. Shin, Marin Abousaud, et al. 2024. “Efficacy of Systemic Bevacizumab for Recurrent Respiratory Papillomatosis with Pulmonary Involvement.” Laryngoscope 134 (2): 577–81. doi:10.1002/lary.30893.